Skip to main content
OpenTrials

Clinical trial condition

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

Explore clinical trials studying Polyradiculoneuropathy, Chronic Inflammatory Demyelinating. Study availability and eligibility vary by location and protocol.

108 public trials 34 recruiting studies
Refine in advanced search Browse all conditions

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating trial results

Completed

Efficacy and Safety Study of I10E in Treatment of Patients With CIDP

NCT02293460

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +13 more
Locations
  • CHU de Bordeaux - Hôpital Pellegrin Bordeaux, France
  • Hôpital général du CHU de Dijon Dijon, France
  • CHU de Nice - Hôpital l'Archet Nice, France
  • CHU Paris - Hôpital Pitié salpétrière Paris, France
View all 33 locations
View Trial Details
Completed

IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements

NCT02414490

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • Neurology at John's Creek Johns Creek, Georgia, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • University of Minnesota Minneapolis, Minnesota, United States
View Trial Details
Completed

Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT02027701

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • Site Reference 8400181 Birmingham, Alabama, United States
  • Site Reference 8400167 Los Angeles, California, United States
  • Site Reference 8400166 Kansas City, Kansas, United States
  • Site Reference 8400169 New York, United States
View all 33 locations
View Trial Details
Completed

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20)

NCT01545076

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • Site reference 8400181 Birmingham, Alabama, United States
  • Site reference 8400173 Phoenix, Arizona, United States
  • Site reference 8400172 Phoenix, Arizona, United States
  • Site reference 8400167 Los Angeles, California, United States
View all 91 locations
View Trial Details

Related conditions